申请人:Esanex, Inc.
公开号:US20200071308A1
公开(公告)日:2020-03-05
Disclosed are compounds and pharmaceutically acceptable salts of Formula I
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, n, Q
1
, Q
2
, Q
3
, Y, and X
1
-X
4
are as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.